More on FHTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Foghorn Therapeutics Inc. (NQ:FHTX)
Delayed: 4.49 -0.18 (3.85%)
Prev. Close $4.67  
Open$4.65 
52 Wk High$ 
52 Wk Low$ 
Day High$4.65 
Day Low$4.46 
P/E N/A  
EPS$ 
Volume396,831 

Friends, Peers and Foes (?): ACRV, GSK, NUVB, RLAY, APRE (more...)

Aug 17, 2026 07:10 AM Foghorn Therapeutics (FHTX) Reiterated at Buy by Stifel Amid Early Pipeline Excitement
Aug 6, 2026 08:02 AM Foghorn Therapeutics Inc. (FHTX) Tops Q2 EPS by 15c
Aug 6, 2026 07:03 AM Form 10-Q Foghorn Therapeutics For: Jun 30
Aug 6, 2026 07:02 AM Form 8-K Foghorn Therapeutics For: Aug 06
Aug 6, 2026 07:01 AM Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
Jul 1, 2026 07:00 AM Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
Jun 25, 2026 04:07 PM Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Lynch Thomas J. Jr.
Jun 25, 2026 04:06 PM Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Duty Stuart
Jun 25, 2026 04:05 PM Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Biller Scott
Jun 25, 2026 04:04 PM Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Gallagher Neil
View All Articles

Entities mentioned with FHTX

View All Entities